Brazil authorizes Butanvac vaccine shot for volunteers in clinical trial By Syndicated Content
Jul 7, 2021 | 4:52 PM
BRASILIA (Reuters) – Brazilian health regulator Anvisa on Wednesday gave the go-ahead for the Butanvac vaccine developed by Sao Paulo’s Butantan Institute biomedical center to be used on volunteers as part of clinical trials.
In a statement, Anvisa said the vaccine will be applied in two doses, 28 days apart. Phase 1 of Butanvac’s clinical trial will involve 400 volunteers, and the first two phases are expected to have 6,000 volunteers in total.
(Reporting by Jamie McGeever; Editing by Leslie Adler) ); } return false; }); $( #comments .commentlist .comment-content a ).attr( target , blank );
Reuters
1 minute read
BRASILIA, July 7 (Reuters) - Brazilian health regulator Anvisa on Wednesday gave the go-ahead for the Butanvac COVID-19 vaccine developed by Sao Paulo s Butantan Institute biomedical center to be used on volunteers in clinical trials.
Anvisa in a statement said the vaccine will be applied in two doses, 28 days apart. Phase I of Butanvac s clinical trial will involve 400 volunteers, and the first two phases are expected to involve 6,000 volunteers in total.
In a separate statement, Butantan said the tests will begin in the coming days in Riberao Preto, a city in the state of Sao Paulo.
Butantan said it has around 10 million doses of the Butanvac shot in stock, which will be used to assess the vaccine s safety and efficacy in the trials. It hopes to have 40 million shots ready for use by October, it added.
Brazil authorizes Butanvac vaccine for volunteers in cl dailymaverick.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymaverick.co.za Daily Mail and Mail on Sunday newspapers.
BRASILIA (REUTERS) - The chief executive of Sinovac Biotech Ltd, the main supplier of Covid-19 vaccines to Brazil, complained last month to Brazilian diplomats in Beijing that anti-China comments in Brasilia were not helping with delayed shipments, two people with knowledge of the matter told Reuters.
Sinovac CEO Yin Weidong suggested an official retraction would make for a more fluid relationship between China and Brazilian President Jair Bolsonaro, the sources said.
Bolsonaro, who complained during his 2018 campaign about a string of Chinese acquisitions in Brazil, said in a speech on May 5 that the coronavirus pandemic could be chemical warfare waged by the fastest growing nation, without naming China.
Sinovac CEO complained about anti-China comments in Brazil: Report Toggle share menu
Advertisement
Sinovac CEO complained about anti-China comments in Brazil: Report
Sinovac Biotech chairman and CEO Yin Weidong attends a government-organized media tour showcasing the company s development of a coronavirus disease (COVID-19) vaccine candidate in Beijing, China, Sep 24, 2020. (Photo: REUTERS/Thomas Peter)
10 Jun 2021 07:05AM Share this content
Bookmark
BRASILIA: The chief executive of Sinovac Biotech, the main supplier of COVID-19 vaccines to Brazil, complained last month to Brazilian diplomats in Beijing that anti-China comments in Brasilia were not helping with delayed shipments, two people with knowledge of the matter told Reuters.